Cernostics

📍 Pittsburgh, United States👥 2 employees💰 Last funded Jan 2019
Biotechnology🌐 tissuecypher.com
Website LinkedIn
Cernostics has joined Castle Biosciences. Please stay connected! https://www.linkedin.com/company/castle-biosciences-inc-/ Cernostics is a diagnostics company focused on delivering next generation cancer diagnostics and prognostics through a unique approach to tissue analysis. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple interacting cell types. Cernostics takes a tissue systems biology approach to anatomic pathology. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics. Learn more about our technology platform [www.cernostics.com] and how it will change the future of cancer diagnostics.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Cernostics?
Cernostics has 1 investors on record on gritt.io.
When did Cernostics last raise funding?
The most recent investment in Cernostics recorded on gritt.io was in January 2019.
What industry is Cernostics in?
Cernostics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Cernostics based?
Cernostics is headquartered in Pittsburgh, United States.